$53.94
-0.46 (-0.85%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
+75.30%
1Y
+44.61%
YTD
+84.22%
Open$54.00
Previous Close$54.40
Day High$55.52
Day Low$52.70
52W High$54.07
52W Low$25.28
Volume—
Avg Volume3.15M
Market Cap8.15B
P/E Ratio17.64
EPS$2.87
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$30.02
Above
SMA 200
$32.89
Above
RSI (14)
46.3
Neutral
Trend
Death Cross
Bearish
Analyst Ratings
Strong Buy
15 analysts
Price Target
+15.7% upside
Current
$53.94
$53.94
Target
$62.39
$62.39
$43.17
$62.39 avg
$72.87
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 584.49M | 1.04B | 1.08B |
| Net Income | 424.10M | 129.57M | 136.18M |
| Profit Margin | 72.6% | 12.5% | 12.7% |
| EBITDA | 117.02M | 169.61M | 170.48M |
| Free Cash Flow | — | 110.01M | 140.89M |
| Rev Growth | +504.9% | +16.6% | +24.3% |
| Debt/Equity | 1.10 | 0.33 | 0.32 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $234.76 | +2.07% | 105.2 | 382.49B |
| AMGN | Amgen Inc | $347.01 | +0.66% | 23.4 | 182.21B |
| GILD | Gilead Sciences Inc | $125.05 | +0.14% | 16.7 | 153.66B |
| VRTX | Vertex Pharmaceuticals Inc | $468.42 | +0.35% | 26.4 | 114.63B |
| REGN | Regeneron Pharmaceuticals | $618.03 | +0.90% | 14.5 | 63.95B |
| ALNY | Alnylam Pharmaceuticals Inc | $288.18 | +0.62% | 64.3 | 37.13B |